Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Veronica Sanchez Bulis

Vp, Corporate Controller at Lyell Immunopharma, Inc. (LYEL)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $97K

Reported trades

Filed Stock Type Shares Price Value Since
Aug 11SEC LYELLyell Immunopharma, Inc. Sell 62114,799 held (−4%) $14.34 $9K -39.3%
Jun 15SEC LYELLyell Immunopharma, Inc. Sell 21715,420 held (−1%) $18.91 $4K -53.9%
Feb 11SEC LYELLyell Immunopharma, Inc. Sell 25415,637 held (−2%) $23.12 $6K -62.3%
Jan 6SEC LYELLyell Immunopharma, Inc. Sell 1,1368,077 held (−12%) $38.67 $44K -77.5%
Jan 6SEC LYELLyell Immunopharma, Inc. Sell 9367,141 held (−12%) $32.32 $30K -73.1%
Nov 12SEC LYELLyell Immunopharma, Inc. Sell 2399,213 held (−3%) $16.10 $4K -45.9%